Skip to content

Intervention Program to Address PTSD in People Living With HIV

Developing and Validating an Integrative Model Incorporating Mindfulness-based Resilience Intervention to Address Post-Traumatic Stress Disorder in People Living With HIV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05588596
Enrollment
82
Registered
2022-10-20
Start date
2020-05-03
Completion date
2021-03-30
Last updated
2022-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS, China, HIV, Mindfulness-based Stress Reduction, PTSD, Resilience

Brief summary

The goal of this randomised controlled trial is to evaluate the efficacy of an integrated intervention program on post-traumatic stress disorder (PTSD) symptoms and related physiological and psychological indicators of people living with HIV (PLWH). The main question it aims to answer are: * to evaluate the efficacy of the intervention program on PTSD symptoms and related physiological and psychological indicators of PLWH through empirical research. * to analyze the mechanism of the intervention. Eligible PLWH were recruited and randomly divided as intervention group and control group. The efficacy of Trauma Resiliency Mindfulness-Informed Intervention on PTSD symptoms and related physiological and psychological indicators in PLWH was evaluated at baseline, after intervention, and 3 months after intervention through this randomized controlled trial. Researchers compared the intervention group and control group to see if it was feasible and had potential clinical value to introduce the Trauma Resiliency Mindfulness-Informed intervention program into the management of PLWH in China.

Interventions

BEHAVIORALTrauma Resiliency Mindfulness-Informed Intervention

The total duration of the intervention was once a week for eight weeks. The aim of the intervention was to teach patients a range of trauma recovery mindfulness skills

Sponsors

Central South University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 18 years or older * been diagnosed with HIV for more than 1 month * screened positive with PTSD CheckList - Civilian Version (PCL-C) * voluntary participation

Exclusion criteria

* impaired Verbal Communication * have received psychological treatment or related psychological intervention in the past three months

Design outcomes

Primary

MeasureTime frameDescription
Change of PTSD symptomsOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the interventionPTSD CheckList - Civilian Version (PCL-C) was used. The scale consists of 17 items divided into 3 dimensions. Each dimension is scored from 1 to 5. The total score of PCL-C ranges from 17 to 85, with higher scores indicating severer PTSD symptoms.

Secondary

MeasureTime frameDescription
Change of depression symptomsOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the interventionThe Zung Self-Rating Depression Scale (SDS) was used. The scale consists of 20 items. Each dimension is scored from 1 to 4. The total score ranges from 20 to 80, with higher scores indicating severer depression symptoms.
Change of resilienceOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the interventionThe Connor-Davidson Resilience Scale (CD-RISC) was used. The scale consists of 25 items. Each dimension is scored from 0 to 4. The total score ranges from 0 to 100, with higher scores indicating higher resilience.
Change of perceived social supportOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the interventionThe Multidimensional Scale of Perceived Social Support (MSPSS) was used. The scale consists of 12 items. Each dimension is scored from 1 to 7. The total score ranges from 12 to 84, with higher scores indicating higher perceived social support.
Change of mindfulnessOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the interventionThe Short Inventory of Mindfulness Capability (SIM-C) was used. The scale consists of 12 items. Each dimension is scored from 1 to 5. The total score ranges from 12 to 60, with higher scores indicating higher mindfulness.
Change of ruminationOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the interventionThe Ruminative Responses Scale (RRS) was used. The scale consists of 22 items. Each dimension is scored from 1 to 4. The total score ranges from 22 to 88, with higher scores indicating higher rumination

Other

MeasureTime frameDescription
Change of medication adherenceOutcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention0 (0%)\ 10 (100%) grade was adopted for scoring. Evaluate the condition of patients taking antiretroviral drugs according to doctor's orders in the past month

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026